Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases

OBJECTIVE: Unlike several other national health agencies, French health authorities recommended that the newer direct oral anticoagulant (DOAC) agents only be prescribed as second choice for the treatment of newly diagnosed non-valvular atrial fibrillation (NVAF), with vitamin K antagonists (VKA) re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Huiart, Laetitia, Ferdynus, Cyril, Renoux, Christel, Beaugrand, Amélie, Lafarge, Sophie, Bruneau, Léa, Suissa, Samy, Maillard, Olivier, Ranouil, Xavier
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2018
Soggetti:
Epidemiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884337/
https://ncbi.nlm.nih.gov/pubmed/29602837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-018180
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi